Fruit of a long term collaboration, Urosphere and its affiliate Urolead (Toulouse) and Institut Curie (Paris) will present a fully characterized biobank of PDXs from bladder cancers and its relevant use as a drug discovery platform.
The results will be presented in poster session A, on Sunday, May 19th and in plenary session 5, on Monday, May 20th.
Title: Establishment of a panel of patient-derived tumor xenograft models recapitulating molecular heterogeneity and drug response of muscle-invasive bladder tumors.
Isabelle Bernard-Pierrot, Institut Curie, Paris, France, poster board number A24
Title: PDX and genetic mouse models for deciphering signaling pathways in bladder cancer.
François R. Radvanyi, Institut Curie, Paris, France, Plenary Session 5: Models for Discovery
Please, do not hesitate to attend these sessions and contact us.
